REVIEW
|
doi:10.20944/preprints202309.0353.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
FDA; Omics technology; Pharmacodynamic biomarkers; biosimilars; Proteomics; Gycomis; Re-ceptor Binding; Pharmacokinetics
Online: 6 September 2023 (03:32:11 CEST)
REVIEW
|
doi:10.20944/preprints202304.1141.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
biosimilarity; biosimilars; pharmacodynamic biomarkers; monoclonal antibodies; FDA; clinical efficacy testing in healthy subjects; clinical efficacy testing in patients; functional assays; receptor binding
Online: 28 April 2023 (08:03:20 CEST)
CASE REPORT
|
doi:10.20944/preprints202402.0658.v3
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
pharmacokinetic-pharmacodynamic interactions; low-dose methotrexate; proton pump inhibitors; analgesics; pancytopenia; hepatotoxicity
Online: 1 April 2024 (11:53:15 CEST)
ARTICLE
|
doi:10.20944/preprints202312.1688.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
fenfluramine; norfenfluramine; enantioselectivity; chiral switch; anticonvulsant activity; pharmacokinetic-pharmacodynamic correlation
Online: 22 December 2023 (09:57:22 CET)